Trending

CRISPR/Cas9

Vertex licenses back CRISPR compounds from German Merck

Vertex licenses back CRISPR compounds from German Merck

US pharma Vertex has licensed back two gene editing compounds that can be used with CRISPR/Cas9 technology, from

X

Vertex licenses back CRISPR compounds from German Merck

https://pharmaphorum.com/news/vertex-licenses-back-crispr-compounds-from-german-merck/

Dr. Dana Carroll to deliver keynote on challenges in Programmable Genome Editing.

Dr. Dana Carroll to deliver keynote on challenges in Programmable Genome Editing.

2nd Genome Editing & Engineering Conference is back!

X

Dr. Dana Carroll to deliver keynote on challenges in Programmable Genome Editing.

https://pharmaphorum.com/partner-content/dr-dana-carroll-deliver-keynote-challenges-programmable-genome-editing/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com